Clinical Trials Logo

Clinical Trial Summary

Study to evaluate the safety, tolerability and antiretroviral activity of a new therapeutic strategy, based on the administration of dasatinib, an ITK, in patients with recent (3-12 months) asymptomatic HIV-1 infection.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05527418
Study type Interventional
Source Institut d'Investigacions Biomèdiques August Pi i Sunyer
Contact Eva Bonfill
Phone +34 932275400
Email bonfill@recerca.clinic.cat
Status Recruiting
Phase Phase 2
Start date January 26, 2024
Completion date June 2026